Table 4 The result of concentration range setting test conducted to evaluate the effect on increase & decrease of reverse mutation colonies by the addition of 23%-GNANA, a test substance, under the presence and absence conditions of metabolic activation system
With and without metabolic activation | Test materials conc.(μg/plate) | Number of colony (cfu/plate) |
Base substitution types | | Frameshift types |
TA100* | TA1535* | WP2uvrA* | | TA98* | TA1537* |
S9Mix(-) | 0# | 102.3±8.08# | 31.7±2.08# | 32.7±4.62# | 46.7±4.73# | 13.3±1.53# |
312 | 108.3±6.81 | 33.7±0.58 | 36.7±1.15 | 50.7±3.06 | 14.0±1.00 |
625 | 109.0±9.54 | 37.3±2.08 | 34.7±4.16 | 51.7±4.73 | 14.3±2.08 |
1,250 | 115.0±3.00 | 35.7±4.16 | 36.0±0.00 | 51.7±2.31 | 11.7±3.06 |
2,500 | 112.3±3.51 | 32.3±1.53 | 36.0±4.36 | 50.3±3.06 | 11.3±2.08 |
5,000 | 124.3±18.88 | 32.3±3.06 | 35.3±3.06 | 49.0±1.00 | 12.3±3.51 |
S9Mix(+) | 0# | 144.7±3.79 | 33.7±2.52 | 35.3±3.06 | 52.7±3.21 | 13.3±0.58 |
312 | 147.3±12.66 | 37.0±2.65 | 32.7±2.31 | 48.0±3.61 | 13.0±2.00 |
625 | 147.0±9.17 | 33.3±4.04 | 34.0±5.29 | 49.0±4.36 | 11.7±0.58 |
1,250 | 139.7±8.33 | 31.7±2.52 | 32.0±4.00 | 51.0±3.00 | 15.7±1.53 |
2,500 | 144.0±5.00 | 33.7±3.21 | 32.0±2.00 | 50.3±3.06 | 12.7±2.08 |
5,000 | 150.0±6.56 | 32.3±3.21 | 31.3±4.16 | 49.3±3.79 | 15.3±2.08 |
Positive control | S9Mix(-) | Materials | NaN3 | NaN3 | 4-NQO | 4-NQO | 9-AA |
Conc. (μg/plate) | 1.5 | 1.5 | 0.5 | 0.5 | 80 |
cfu/plate | 357.7±9.61 | 159.3±8.62 | 260.0±24.98 | 252.7±4.93 | 136.0±7.00 |
S9Mix(+) | Materials | 2-AA | 2-AA | 2-AA | 2-AA | 2-AA |
Conc. (μg/plate) | 1.0 | 2.0 | 10 | 0.5 | 2.0 |
cfu/plate | 372.7±13.01 | 160.0±22.72 | 283.3±20.03 | 259.3±22.48 | 204.7±15.31 |
*: TA98 (Sal. typhimurium TA98), TA100 (Sal. typhimurium TA100), TA1535 (Sal. typhimurium TA1535), TA1537 (Sal. typhimurium TA1537), WP2uvrA (E. coli WP2uvrA), #: Represents a significant difference at p<0.01 level compared with the vehicle control